Application of high-risk human papillomavirus testing in women with cervical abnormal cytology
ZHANG Xiaoyan1, DING Xiaoping1, YE Mei1, BIAN Meilu2, CHEN Qingyun2
1.Department of Obstetrics and Gynecology, The Second Artillery General Hospital of PLA, Beijing 100088, China; 2.Department of Obstetrics and Gynecology ,China-Japan Friendship Hospital, Beijing 100029,China
Abstract:Objective To investigate the application value of HR-HPV testing in cervical lesion screening. Method 872 patients interpreted as having abnormal cervical cytology received HR-HPV testing and all patients underwent colposcopy and biopsy. The patients were divided into five groups of NILM, CINI, CINII, CINIII and ICC. Association between HR-HPV load and CINs were evaluated by Spearman rank correlation. Result The positive rates of HR-HPV in ASC-US, ASC-H, LSIL, HSIL were 31.6%, 59.7%, 50.3%, 89.6%, respectively(P<0.01). The positive rates of HR-HPV in NILM, CINI, CINII, CINIII and ICC were 25.2%, 53.4%, 86.7%, 96.4%, 100%, respectively(P<0.01). There was significant difference between the viral load in NILM and CINs or ICC,while no significant difference was observed among the viral load in CINI, CINII, CINIII and ICC. Conclusions The positive rate of HR-HPV increases with the gravity of cervical lesion. The HR-HPV viral load is significantly associated with the presence of CINs and ICC. HPV viral load does not increase with severity of cervical neoplasia.
Jarboe E A, Venkat P, Hirsch M S,et al. A weakly positive human papillomavirus Hybrid Capture II result correlates with a significantly lower risk of cervical intraepithelial neoplasia 2,3 after atypical squamous cells of undetermined significance cytology[J].J Low Genit Tract Dis,2010,14:174-178.
[1]
Kanjanavirojkul N, Pairojkul C, Yuenyao P,et al. Risk factors and histological outcome of abnormal cervix with human papilloma infection in northeastern Thai-women[J].Asian Pac J Cancer Prev, 2006,7(4):567-570.
[2]
Mesher D, Szarewski A, Cadman L,et al. Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study[J].Br J Cancer, 2010,102(9):1405-1410.
[3]
Torres L M, Insaurralde A, Rodriguez M I,et al. Detection of high risk human papillomavirus cervical infections by the hybrid capture in Asuncion, Paraguay[J].Braz J Infect Dis, 2009,13(3):203-206.
Jarboe E A, Venkat P, Hirsch M S,et al. A weakly positive human papillomavirus Hybrid Capture II result correlates with a significantly lower risk of cervical intraepithelial neoplasia 2,3 after atypical squamous cells of undetermined significance cytology[J].J Low Genit Tract Dis,2010,14:174-178.
[6]
Onuma K,Saad R S,Kanbour-shakir A,et al.Clinical implications of the diagnosis "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion" in pregnant women[J].Cancer,2006,108:282-287.
Nielsen A, Kjaer S K, Munk C, et al.Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women[J].J Med Virol, 2010,82(4):616-623.
[6]
Onuma K,Saad R S,Kanbour-shakir A,et al.Clinical implications of the diagnosis "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion" in pregnant women[J].Cancer,2006,108:282-287.
Nielsen A, Kjaer S K, Munk C, et al.Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women[J].J Med Virol, 2010,82(4):616-623.
[11]
Williams C, Collins S I, Roberts S,et al. Is human papillomavirus viral load a clinically useful predictive marker? a longitudinal study[J].Cancer Epidemiol Biomarkers Prev,2010,19(3):832-837.
Badaracco G, Savarese A, Micheli A,et al. Persistence of HPV after radio-chemotherapy in locally advanced cervical cancer[J].Oncol Rep,2010,23(4):1093-1099.
Williams C, Collins S I, Roberts S,et al. Is human papillomavirus viral load a clinically useful predictive marker? a longitudinal study[J].Cancer Epidemiol Biomarkers Prev,2010,19(3):832-837.
[12]
Badaracco G, Savarese A, Micheli A,et al. Persistence of HPV after radio-chemotherapy in locally advanced cervical cancer[J].Oncol Rep,2010,23(4):1093-1099.